Report Detail
Global (United States, European Union and China) Huntington Disease Protein Market Research Report 2019-2025
- RnM3368669 |
- 14 July, 2020 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Huntington Disease Protein market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Huntington Disease Protein market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Huntington Disease Protein market is segmented into
NI-302
NLF-HD
P-301905
IONIS-HTTRx
Others
Segment by Application, the Huntington Disease Protein market is segmented into
Alzheimer's Disease
Kennedy's Disease
Spinocerebellar Ataxia
Others
Regional and Country-level Analysis
The Huntington Disease Protein market is analysed and market size information is provided by regions (countries).
The key regions covered in the Huntington Disease Protein market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Huntington Disease Protein Market Share Analysis
Huntington Disease Protein market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Huntington Disease Protein business, the date to enter into the Huntington Disease Protein market, Huntington Disease Protein product introduction, recent developments, etc.
The major vendors covered:
AFFiRiS AG
Ionis Pharmaceuticals, Inc.
Neurimmune Holding AG
nLife Therapeutics, S.L.
reMYND NV
Sangamo BioSciences, Inc.
UniQure N.V.
Voyager Therapeutics, Inc.
Vybion, Inc.
WAVE Life Sciences Ltd.
1 Study Coverage
- 1.1 Huntington Disease Protein Product Introduction
- 1.2 Market Segments
- 1.3 Key Huntington Disease Protein Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Huntington Disease Protein Market Size Growth Rate by Type
- 1.4.2 NI-302
- 1.4.3 NLF-HD
- 1.4.4 P-301905
- 1.4.5 IONIS-HTTRx
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global Huntington Disease Protein Market Size Growth Rate by Application
- 1.5.2 Alzheimer's Disease
- 1.5.3 Kennedy's Disease
- 1.5.4 Spinocerebellar Ataxia
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Huntington Disease Protein Market Size, Estimates and Forecasts
- 2.1.1 Global Huntington Disease Protein Revenue 2015-2026
- 2.1.2 Global Huntington Disease Protein Sales 2015-2026
- 2.2 Global Huntington Disease Protein, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Huntington Disease Protein Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Huntington Disease Protein Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Huntington Disease Protein Competitor Landscape by Players
- 3.1 Huntington Disease Protein Sales by Manufacturers
- 3.1.1 Huntington Disease Protein Sales by Manufacturers (2015-2020)
- 3.1.2 Huntington Disease Protein Sales Market Share by Manufacturers (2015-2020)
- 3.2 Huntington Disease Protein Revenue by Manufacturers
- 3.2.1 Huntington Disease Protein Revenue by Manufacturers (2015-2020)
- 3.2.2 Huntington Disease Protein Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Huntington Disease Protein Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Huntington Disease Protein Revenue in 2019
- 3.2.5 Global Huntington Disease Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Huntington Disease Protein Price by Manufacturers
- 3.4 Huntington Disease Protein Manufacturing Base Distribution, Product Types
- 3.4.1 Huntington Disease Protein Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Huntington Disease Protein Product Type
- 3.4.3 Date of International Manufacturers Enter into Huntington Disease Protein Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Huntington Disease Protein Market Size by Type (2015-2020)
- 4.1.1 Global Huntington Disease Protein Sales by Type (2015-2020)
- 4.1.2 Global Huntington Disease Protein Revenue by Type (2015-2020)
- 4.1.3 Huntington Disease Protein Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Huntington Disease Protein Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Huntington Disease Protein Sales Forecast by Type (2021-2026)
- 4.2.2 Global Huntington Disease Protein Revenue Forecast by Type (2021-2026)
- 4.2.3 Huntington Disease Protein Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Huntington Disease Protein Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Huntington Disease Protein Market Size by Application (2015-2020)
- 5.1.1 Global Huntington Disease Protein Sales by Application (2015-2020)
- 5.1.2 Global Huntington Disease Protein Revenue by Application (2015-2020)
- 5.1.3 Huntington Disease Protein Price by Application (2015-2020)
- 5.2 Huntington Disease Protein Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Huntington Disease Protein Sales Forecast by Application (2021-2026)
- 5.2.2 Global Huntington Disease Protein Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Huntington Disease Protein Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Huntington Disease Protein by Country
- 6.1.1 North America Huntington Disease Protein Sales by Country
- 6.1.2 North America Huntington Disease Protein Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Huntington Disease Protein Market Facts & Figures by Type
- 6.3 North America Huntington Disease Protein Market Facts & Figures by Application
7 Europe
- 7.1 Europe Huntington Disease Protein by Country
- 7.1.1 Europe Huntington Disease Protein Sales by Country
- 7.1.2 Europe Huntington Disease Protein Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Huntington Disease Protein Market Facts & Figures by Type
- 7.3 Europe Huntington Disease Protein Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Huntington Disease Protein by Region
- 8.1.1 Asia Pacific Huntington Disease Protein Sales by Region
- 8.1.2 Asia Pacific Huntington Disease Protein Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Huntington Disease Protein Market Facts & Figures by Type
- 8.3 Asia Pacific Huntington Disease Protein Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Huntington Disease Protein by Country
- 9.1.1 Latin America Huntington Disease Protein Sales by Country
- 9.1.2 Latin America Huntington Disease Protein Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Huntington Disease Protein Market Facts & Figures by Type
- 9.3 Central & South America Huntington Disease Protein Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Huntington Disease Protein by Country
- 10.1.1 Middle East and Africa Huntington Disease Protein Sales by Country
- 10.1.2 Middle East and Africa Huntington Disease Protein Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Huntington Disease Protein Market Facts & Figures by Type
- 10.3 Middle East and Africa Huntington Disease Protein Market Facts & Figures by Application
11 Company Profiles
- 11.1 AFFiRiS AG
- 11.1.1 AFFiRiS AG Corporation Information
- 11.1.2 AFFiRiS AG Description and Business Overview
- 11.1.3 AFFiRiS AG Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AFFiRiS AG Huntington Disease Protein Products Offered
- 11.1.5 AFFiRiS AG Related Developments
- 11.2 Ionis Pharmaceuticals, Inc.
- 11.2.1 Ionis Pharmaceuticals, Inc. Corporation Information
- 11.2.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
- 11.2.3 Ionis Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Products Offered
- 11.2.5 Ionis Pharmaceuticals, Inc. Related Developments
- 11.3 Neurimmune Holding AG
- 11.3.1 Neurimmune Holding AG Corporation Information
- 11.3.2 Neurimmune Holding AG Description and Business Overview
- 11.3.3 Neurimmune Holding AG Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Neurimmune Holding AG Huntington Disease Protein Products Offered
- 11.3.5 Neurimmune Holding AG Related Developments
- 11.4 nLife Therapeutics, S.L.
- 11.4.1 nLife Therapeutics, S.L. Corporation Information
- 11.4.2 nLife Therapeutics, S.L. Description and Business Overview
- 11.4.3 nLife Therapeutics, S.L. Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 nLife Therapeutics, S.L. Huntington Disease Protein Products Offered
- 11.4.5 nLife Therapeutics, S.L. Related Developments
- 11.5 reMYND NV
- 11.5.1 reMYND NV Corporation Information
- 11.5.2 reMYND NV Description and Business Overview
- 11.5.3 reMYND NV Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 reMYND NV Huntington Disease Protein Products Offered
- 11.5.5 reMYND NV Related Developments
- 11.6 Sangamo BioSciences, Inc.
- 11.6.1 Sangamo BioSciences, Inc. Corporation Information
- 11.6.2 Sangamo BioSciences, Inc. Description and Business Overview
- 11.6.3 Sangamo BioSciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Sangamo BioSciences, Inc. Huntington Disease Protein Products Offered
- 11.6.5 Sangamo BioSciences, Inc. Related Developments
- 11.7 UniQure N.V.
- 11.7.1 UniQure N.V. Corporation Information
- 11.7.2 UniQure N.V. Description and Business Overview
- 11.7.3 UniQure N.V. Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 UniQure N.V. Huntington Disease Protein Products Offered
- 11.7.5 UniQure N.V. Related Developments
- 11.8 Voyager Therapeutics, Inc.
- 11.8.1 Voyager Therapeutics, Inc. Corporation Information
- 11.8.2 Voyager Therapeutics, Inc. Description and Business Overview
- 11.8.3 Voyager Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Voyager Therapeutics, Inc. Huntington Disease Protein Products Offered
- 11.8.5 Voyager Therapeutics, Inc. Related Developments
- 11.9 Vybion, Inc.
- 11.9.1 Vybion, Inc. Corporation Information
- 11.9.2 Vybion, Inc. Description and Business Overview
- 11.9.3 Vybion, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Vybion, Inc. Huntington Disease Protein Products Offered
- 11.9.5 Vybion, Inc. Related Developments
- 11.10 WAVE Life Sciences Ltd.
- 11.10.1 WAVE Life Sciences Ltd. Corporation Information
- 11.10.2 WAVE Life Sciences Ltd. Description and Business Overview
- 11.10.3 WAVE Life Sciences Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 WAVE Life Sciences Ltd. Huntington Disease Protein Products Offered
- 11.10.5 WAVE Life Sciences Ltd. Related Developments
- 11.1 AFFiRiS AG
- 11.1.1 AFFiRiS AG Corporation Information
- 11.1.2 AFFiRiS AG Description and Business Overview
- 11.1.3 AFFiRiS AG Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AFFiRiS AG Huntington Disease Protein Products Offered
- 11.1.5 AFFiRiS AG Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Huntington Disease Protein Market Estimates and Projections by Region
- 12.1.1 Global Huntington Disease Protein Sales Forecast by Regions 2021-2026
- 12.1.2 Global Huntington Disease Protein Revenue Forecast by Regions 2021-2026
- 12.2 North America Huntington Disease Protein Market Size Forecast (2021-2026)
- 12.2.1 North America: Huntington Disease Protein Sales Forecast (2021-2026)
- 12.2.2 North America: Huntington Disease Protein Revenue Forecast (2021-2026)
- 12.2.3 North America: Huntington Disease Protein Market Size Forecast by Country (2021-2026)
- 12.3 Europe Huntington Disease Protein Market Size Forecast (2021-2026)
- 12.3.1 Europe: Huntington Disease Protein Sales Forecast (2021-2026)
- 12.3.2 Europe: Huntington Disease Protein Revenue Forecast (2021-2026)
- 12.3.3 Europe: Huntington Disease Protein Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Huntington Disease Protein Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Huntington Disease Protein Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Huntington Disease Protein Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Huntington Disease Protein Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Huntington Disease Protein Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Huntington Disease Protein Sales Forecast (2021-2026)
- 12.5.2 Latin America: Huntington Disease Protein Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Huntington Disease Protein Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Huntington Disease Protein Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Huntington Disease Protein Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Huntington Disease Protein Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Huntington Disease Protein Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Huntington Disease Protein Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Huntington Disease Protein Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Huntington Disease Protein. Industry analysis & Market Report on Huntington Disease Protein is a syndicated market report, published as Global (United States, European Union and China) Huntington Disease Protein Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Huntington Disease Protein market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
